Holen Sie sich die Stockscreener-App
336.18
0.36%
1.19
Handel nachbörslich:
336.18
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Capital World Investors Sells 129,455 Shares of Penumbra, Inc. $PEN - MarketBeat
Risk Report: Is Penumbra Inc likely to announce a buybackBreakout Watch & Smart Allocation Stock Reports - baoquankhu1.vn
Can Penumbra Inc. (0P8) stock sustain double digit ROEEntry Point & Daily Risk Controlled Trade Plans - Naître et grandir
Gap Down: What is Penumbra Inc. s debt to equity ratio2025 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Analyst Downgrade: Will Penumbra Inc. stock rally after Fed decisions2025 Dividend Review & Expert Curated Trade Ideas - Naître et grandir
Aug Shorts: What is the long term forecast for Penumbra Inc stock2025 Technical Patterns & Expert Approved Trade Ideas - baoquankhu1.vn
Picton Mahoney Asset Management Takes $1.03 Million Position in Penumbra, Inc. $PEN - MarketBeat
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages - The Motley Fool
Blood Clot Retrieval Devices Market Size, Share & Forecast to 2036 - Fact.MR
Insider Sell: Maggie Yuen Sells Shares of Penumbra Inc (PEN) - GuruFocus
Insider Selling: Penumbra (NYSE:PEN) CFO Sells 2,432 Shares of Stock - MarketBeat
NZS Capital LLC Buys 17,355 Shares of Penumbra, Inc. $PEN - MarketBeat
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—THR, PEN, BCO, and ALGT - Carroll County Mirror-Democrat
Champlain Investment Partners LLC Trims Holdings in Penumbra, Inc. $PEN - MarketBeat
Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future - Sahm
Broker files Form 144 reporting PEN share sales (NYSE: PEN) - Stock Titan
(PEN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise - The Globe and Mail
Penumbra, Inc. (PEN) Stock Analysis: Unveiling the Potential in Medical Devices with a 4.57% Upside - DirectorsTalk Interviews
Citigroup Inc. Grows Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
PEN shares climb after surpassing Q4 earnings and revenue expectations, with improved profit margins - Bitget
TD Asset Management Inc Sells 8,742 Shares of Penumbra, Inc. $PEN - MarketBeat
Artisan Partners Limited Partnership Raises Position in Penumbra, Inc. $PEN - MarketBeat
PEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Penumbra, Inc. $PEN Shares Acquired by Intech Investment Management LLC - MarketBeat
UBS Maintains Neutral on Penumbra (PEN) Feb 26, 2026 - Meyka
Penumbra (PEN) Earnings Surge Challenges Concerns Over Rich 75x P/E Valuation - simplywall.st
UBS reiterates Neutral on Penumbra stock, keeps $374 target By Investing.com - Investing.com Canada
Evercore ISI Maintains Outperform Rating and Raises PT for PEN t - GuruFocus
UBS reiterates Neutral on Penumbra stock, keeps $374 target - Investing.com
Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Decoding Penumbra Inc (PEN): A Strategic SWOT Insight - GuruFocus
Boston Scientific Still Navigating the Regulatory Process to Acquire Penumbra - Morningstar
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | BSX Stock News - Longbridge
Evercore ISI Maintained Outperform for Penumbra, Inc. (PEN) Feb 25, 2026 - Meyka
Evercore ISI raises Penumbra stock price target on embolization growth - Investing.com Nigeria
Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025 - Finviz
Evercore ISI raises Penumbra stock price target on embolization growth By Investing.com - Investing.com South Africa
Penumbra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financi - GuruFocus
Penumbra: Fourth Quarter Earnings Overview - Bitget
Penumbra (NYSE:PEN) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Penumbra Inc SEC 10-K Report - TradingView
Penumbra: Q4 Earnings Snapshot - marketscreener.com
Penumbra Q4 Non-GAAP Earnings, Revenue Rise - marketscreener.com
Penumbra Inc. (PEN) Releases Q4 2025 Earnings: Revenue and EPS Beat, Strong YoY Growth - Quiver Quantitative
Earnings Flash (PEN) Penumbra, Inc. Reports Q4 Revenue $385.4M, vs. FactSet Est of $361.9M - marketscreener.com
Earnings Flash (PEN) Penumbra, Inc. Posts Q4 Adjusted EPS $1.18 per Share, vs. FactSet Est of $1.11 - marketscreener.com
Penumbra Q4 Earnings Assessment - Benzinga
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Penumbra (NYSE: PEN) grows 2025 revenue 17.5% amid BSX acquisition - Stock Titan
Penumbra Inc (NYSE:PEN) Combines Strong Fundamentals with Bullish Technical Setup - ChartMill
Penumbra, Inc. (PEN) Stock Analysis: Navigating Healthcare Innovation with a 2.70% Upside - DirectorsTalk Interviews
Penumbra earnings on deck as Boston Scientific deal looms By Investing.com - Investing.com South Africa
Neurovascular Devices Market Size, Share Growth Report 2034 - Fortune Business Insights
PEN (Penumbra) Retained Earnings : $190 Mil (As of Sep. 2025) - GuruFocus
PEN (Penumbra) Sale Of Investment : $18 Mil (TTM As of Sep. 2025) - GuruFocus
Chipmakers Recap: Is Penumbra Inc on track to beat earnings2025 Major Catalysts & Safe Capital Allocation Plans - baoquankhu1.vn
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):